Literature DB >> 25762455

amamutdb.no: A relational database for MAN2B1 allelic variants that compiles genotypes, clinical phenotypes, and biochemical and structural data of mutant MAN2B1 in α-mannosidosis.

Hilde Monica Frostad Riise Stensland1, Gabrio Frantzen2, Elina Kuokkanen3, Elisabeth Kjeldsen Buvang4, Helle Bagterp Klenow1, Pirkko Heikinheimo3, Dag Malm5, Øivind Nilssen1,4.   

Abstract

α-Mannosidosis is an autosomal recessive lysosomal storage disorder caused by mutations in the MAN2B1 gene, encoding lysosomal α-mannosidase. The disorder is characterized by a range of clinical phenotypes of which the major manifestations are mental impairment, hearing impairment, skeletal changes, and immunodeficiency. Here, we report an α-mannosidosis mutation database, amamutdb.no, which has been constructed as a publicly accessible online resource for recording and analyzing MAN2B1 variants (http://amamutdb.no). Our aim has been to offer structured and relational information on MAN2B1 mutations and genotypes along with associated clinical phenotypes. Classifying missense mutations, as pathogenic or benign, is a challenge. Therefore, they have been given special attention as we have compiled all available data that relate to their biochemical, functional, and structural properties. The α-mannosidosis mutation database is comprehensive and relational in the sense that information can be retrieved and compiled across datasets; hence, it will facilitate diagnostics and increase our understanding of the clinical and molecular aspects of α-mannosidosis. We believe that the amamutdb.no structure and architecture will be applicable for the development of databases for any monogenic disorder.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  MAN2B1; Mutation database; alpha-mannosidosis; lysosomal disorder

Mesh:

Substances:

Year:  2015        PMID: 25762455     DOI: 10.1002/humu.22787

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  4 in total

1.  Defining a new immune deficiency syndrome: MAN2B2-CDG.

Authors:  Jan Verheijen; Sunnie Y Wong; Jared H Rowe; Kimiyo Raymond; Jennifer Stoddard; Ottavia M Delmonte; Marita Bosticardo; Kerry Dobbs; Julie Niemela; Enrica Calzoni; Sung-Yun Pai; Uimook Choi; Yasuhiro Yamazaki; Anne Marie Comeau; Erin Janssen; Lauren Henderson; Melissa Hazen; Gerard Berry; Sergio D Rosenzweig; Hasan Hamdan Aldhekri; Miao He; Luigi D Notarangelo; Eva Morava
Journal:  J Allergy Clin Immunol       Date:  2019-11-24       Impact factor: 10.793

2.  Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation.

Authors:  Line Borgwardt; Hilde Monica Frostad Riise Stensland; Klaus Juul Olsen; Flemming Wibrand; Helle Bagterp Klenow; Michael Beck; Yasmina Amraoui; Laila Arash; Jens Fogh; Øivind Nilssen; Christine I Dali; Allan Meldgaard Lund
Journal:  Orphanet J Rare Dis       Date:  2015-06-06       Impact factor: 4.123

3.  Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma.

Authors:  Xuelei Lin; Hongwei Liu; Hongyu Zhao; Shunjin Xia; Yueshuo Li; Chaoqian Wang; Qi Huang; Siyi Wanggou; Xuejun Li
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

Review 4.  Alpha-Mannosidosis: Therapeutic Strategies.

Authors:  Maria Rachele Ceccarini; Michela Codini; Carmela Conte; Federica Patria; Samuela Cataldi; Matteo Bertelli; Elisabetta Albi; Tommaso Beccari
Journal:  Int J Mol Sci       Date:  2018-05-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.